AbbVie Inc. (ABBV)
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 194.02 |
| Open | 193.86 |
| Bid | 192.68 x 900 |
| Ask | 194.37 x 800 |
| Day's Range | 191.81 - 194.57 |
| 52 Week Range | 135.85 - 199.95 |
| Volume | |
| Avg. Volume | 5,245,945 |
| Market Cap | 343.041B |
| Beta (5Y Monthly) | 0.62 |
| PE Ratio (TTM) | 64.95 |
| EPS (TTM) | 2.99 |
| Earnings Date | Oct 25, 2024 - Oct 29, 2024 |
| Forward Dividend & Yield | 6.20 (3.19%) |
| Ex-Dividend Date | Oct 15, 2024 |
| 1y Target Est | 197.33 |
ZacksAbbVie (ABBV) Is Considered a Good Investment by Brokers: Is That True?
According to the average brokerage recommendation (ABR), one should invest in AbbVie (ABBV). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
ZacksFDA Grants Label Expansion to J&J's Tremfya in Ulcerative Colitis
With this latest approval, JNJ's Tremfya is approved for a total of three immunology indications.
ZacksHere is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
AbbVie (ABBV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
© 2024 Yahoo. All rights reserved.